Clinical Evaluation of Hydralazine (Apresoline) Alone and in Combination with Veriloid in the Treatment of Hypertension

Gross, F. , Drury, J. , AND Meier, R. : New Group of Depressor Substances with Special Type of Effect. Experientia 6: 19, 1950.

Craver, B.W. AND Yankman, F.F. : Some Pharmacological Properties of I-Hydrazinophthalazine, a Hypotensive Agent. Federation Proc. 9: 265, 1950.

Grimson, K.S. , Chittum, J.R. , AND Metcalf, B.H. : Action of I-Hydrazinophthalazine (c-5968) on Vasomotor Reflexes and Hypertension in Dogs and Man. Federation Proc. 9: 279, 1950.

Craver, B.W. , Barrett, W. , Cameron, A. , AND Yankman, F.F. : Activities of I-Hydrazinophthalazine (Ba-5968): Hypotensive Agent. J. Am. Pharm. A. 40: 559, 1951.

Schroeder, H.A. : Effect of I-Hydrazinophthalazine in Hypertension . Circulation 5: 28, 1952.

Johnson, R.L. , Freis, E.D. , AND Schnaper , H.W. : Clinical Evaluation of I-Hydrazinophthalazine (c-5968) in Hypertension with Special Reference to Alternating Treatment with Hexamethonium. Circulation 5: 833, 1952.

Taylor, R.D. , Dustan, H.P. , Corcoran, A.C. , AND Page, I.H. : Evaluation of I-Hydrazinophthalazine ("Apresoline") in Treatment of Hypertension Disease. Arch. Int. Med. 90: 734, 1952.

Hafkenschiel J.H. AND Lindauer, M.A. : I-Hydrazinophthalazine (Apresoline) in Treatment of Hypertension: Two-year study. Circulation 7: 52, 1952.

Reuse, F.C. : Renal Hyperemia Induced in Man by New Phthalazine Derivative. Proc. Soc. Exper. Biol. & Med. 73: 102, 1950.

Brittan, J.B. , Taylor, I.P. , AND Ahlquist , R.P. : Cardiovascular Actions of 2,3-Benzo-Diazine-4-Hydrazine (C-5968). Federation Proc. 10: 282, 1951.

Freis, E.D. , Mackay, J.C. , AND Oliver, W.F. : Effect of "Sympatholitic" Drugs on Cardiovascular Responses to Epinephrine and Norepinephrine in Man. Circulalation 3: 254, 1951.

Helmer, O.M. Cited by Schroeder , H.A. : Control of Hypertension by Hexamethonium and I-Hydrazinophthalazine: Preliminary Report. Arch. Int. Med. 89: 523, 1952.

Taylor, R.D. , Page, I.H. , AND Corcoran , A.C. : Hormonal Neuraginic Vasopressor Mechanism. Arch. Int. Med. 88:1,1951.

Goldring, W. , Chasis, H. , Ranges, H.A. , AND Smith, H.W. : Effective Renal Blood Flow in Subjects with Essential Hypertension. J. Clin. Investigation 20: 637, 1941.

Meilman, E. : Clinical Studies on Veratrum Alkaloids III Effect of Protoveratrine on Renal Function in Man. J. Clin. Investigation 32: 80,1953.

Wilkinson, E.L. , Backman, H. , AND Hecht, H.H. : Cardiovascular and Renal Adjustments to New Hypertensive agent (Ciba-5968). Am. J. Med. 13: 101, 1952.

Mayer, J.H. , Handley, C.A. , AND Huggins, R.A. : Some Pharmacodynamic Effects of I-Hydrazinophthalazine (C-5968) with Particular Reference to Renal Function and Cardiovascular response . J. Pharmacol. & Exper. Therap. 103: 368, 1951 .

Wilkins, R.W. : New Drug Therapies in Arterial Hypertension . Ann. Int. Med. 37: 1144, 1952.

Smithwick, R.H. : The Effect of Sympathectomy upon the Mortality and Survival Rates of Patients with Hypertensive Cardiovascular Disease. In Hypertension. Edited by E. T. Bell , University of Minnesota Press, 1951. P. 441.

Nomenclature and Criteria for Diagnosis of Diseases of the Heart by the Criteria Committee of the New York Heart Association. 1945. J. J. Little and Ives Co., New York.

Kaufman, M. : Pancytopenia from Hydralazine. J. A. M. A. 151: 1488 1953.

Moser, M. , Syner, J. , Malitz, S. , AND Mattingly, T.W. : Acute Psychosis as a Complication of Hydralazine therapy in Essential Hypertension . J. A. M. A. 152: 1329 1953.

Cohen, B.M. : Fatal Reaction to I-Hydrazinophthalazine (Apresoline) . Amer. Heart J. 45: 931, 1953.